Ozempic

Ozempic is a prescription medication for type 2 diabetes. Its active ingredient, semaglutide, is a GLP-1 receptor agonist. Administered through subcutaneous injections, Ozempic helps regulate blood sugar levels by increasing insulin release, reducing liver glucose production, and slowing stomach emptying. It's designed to improve glycemic control and may have additional benefits for weight management. Use it as directed by your healthcare provider.

The active ingredient in Ozempic is semaglutide. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, and it works by mimicking the action of the natural hormone GLP-1. This helps regulate blood sugar levels by increasing insulin release and reducing the production of glucose by the liver. Semaglutide also slows down the rate at which food is absorbed from the stomach, promoting a feeling of fullness and reducing appetite. It is an important component in the management of type 2 diabetes.

Ozempic (semaglutide) comes with essential warnings. There's an increased risk of pancreatitis, so seek medical attention for persistent abdominal pain. It can elevate the risk of hypoglycemia, requiring regular blood sugar monitoring. The relevance of thyroid C-cell tumors in rodents to humans is uncertain; discuss any relevant family history. There's a potential for acute kidney injury, particularly in those with pre-existing kidney issues, necessitating regular monitoring.